Use of BNP and CRP as Biomarkers in Assessing Cardiovascular Disease:Diagnosis Versus Risk

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|5|1|15-25

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.5, Iss.1, 2007-01, pp. : 15-25

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pre-eclampsia Versus Cardiovascular Disease Versus CRP

By  

Current Hypertension Reviews, Vol. 2, Iss. 4, 2006-11 ,pp. : 317-323

Bentham Science Publishers

Access to resources Recommend Favorite

A Novel Panel of Cerebrospinal Fluid Biomarkers for the Differential Diagnosis of Alzheimer’s Disease versus Normal Aging and Frontotemporal Dementia

By  

Dementia and Geriatric Cognitive Disorders, Vol. 24, Iss. 6, 2007-10 ,pp. : 434-440

Karger

Access to resources Recommend Favorite

Prognostic value of NT-pro-BNP and hs-CRP for risk stratification in primary care: results from the population-based DETECT study

By Leistner David   Klotsche Jens   Pieper Lars   Palm Sylvia   Stalla Günter   Lehnert Hendrik   Silber Sigmund   März Winfried   Wittchen Hans-Ulrich   Zeiher Andreas  

Clinical Research in Cardiology, Vol. 102, Iss. 4, 2013-04 ,pp. : 259-268

Springer Publishing Company

Access to resources Recommend Favorite

Scoring the risk in cardiovascular disease

By Hoke Matthias  

Interventional Cardiology, Vol. 5, Iss. 3, 2013-06 ,pp. : 239-241

Future Medicine

Access to resources Recommend Favorite

The Utility of Emerging Biomarkers and Imaging for Assessment of Cardiovascular Risk

By  

Current Vascular Pharmacology, Vol. 10, Iss. 6, 2012-11 ,pp. : 712-714

Bentham Science Publishers

Access to resources Recommend Favorite